Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Celularity Inc. (CELUW)

  • Technical Exchange News
  • May 01, 2025, 05:43 UTC
  • 12

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Delinquent.

Comment Full text

Celularity Inc. (CELU)

  • Technical Exchange News
  • May 01, 2025, 05:43 UTC
  • 13

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Delinquent.

Comment Full text

BioNexus Gene Lab Corp (BGLC)

  • Technical Exchange News
  • May 01, 2025, 05:43 UTC
  • 13

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Artelo Biosciences Inc. (ARTL)

  • Technical Exchange News
  • May 01, 2025, 05:43 UTC
  • 13

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

ALX Oncology Inc (ALXO)

  • Technical Exchange News
  • May 01, 2025, 05:43 UTC
  • 12

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

PAVmed Inc (PAVMZ)

  • Technical Exchange News
  • May 01, 2025, 00:25 UTC
  • 15

NASDAQ traded attribute type Security_Name was changed. Previous value: PAVmed Inc. - Series Z Warrant. New value: PAVmed Inc. - Series Z Warrant.

Comment Full text

PAVmed Inc (PAVMZ)

  • Technical Exchange News
  • May 01, 2025, 00:25 UTC
  • 14

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: PAVmed Inc. - Series Z Warrant.

Comment Full text

PAVmed Inc (PAVMZ)

  • Technical Exchange News
  • May 01, 2025, 00:25 UTC
  • 14

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: PAVmed Inc. - Series Z Warrant.

Comment Full text

Scilex Holding Co (SCLX)

  • Technical Exchange News
  • April 30, 2025, 22:44 UTC
  • 12

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Celularity Inc. (CELU)

  • Technical Exchange News
  • April 30, 2025, 22:43 UTC
  • 12

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Delinquent.

Comment Full text
  • Previous
  • 49
  • 50
  • 51
  • 52
  • 53
  • Next

Search

News categories

  • Technical Exchange News(9489)
  • Event(407)
  • SEC News(155613)
  • FDA Approval(8878)
  • Company Report(721)
  • Business News(105641)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin